Immunohistochemistry (IHC) analysis revealed that ID1 is expressed by a small minority of cells (range 0.5–6% of total cancer cells) in ~50% of ER-negative disease, namely TNBC and Her2+ tumors (Supplementary Figures 1A,B). This evidence concerns the gene ID1 and cancer.